
- Volume 0 0
Yes, Virginia, There Is an Asthma Gene
Researchers have discovered a gene thatseems to influence susceptibility to asthma.Furthermore, the CYFIP2 protein producedby the gene could serve as a target for newasthma drugs, according to a study reportedin the American Journal of Respiratory andCritical Care Medicine (July 15, 2005).
In an earlier study, the researchers connectedmapped areas on chromosome 5in patients with allergic asthma. For thecurrent study, the researchers took theevidence a step beyond by identifying agene in this region that influences asthmavulnerability. The investigators performedgenetic screening in 155 families withasthma. The results showed 6 DNAchanges that affect the development ofasthma. These mutations were found in agene for CYFIP2. Further examinationsuggested that CYFIP2 impacts the risk ofasthma by affecting the function of T cells.The investigators said that more testing isneeded to explain how changes in thesecells may promote asthma.
Articles in this issue
about 20 years ago
A Pharmacist's Guide to OTC Therapy: Ocular Care Productsabout 20 years ago
Dangerous Liaisons: Schizophrenia and Diabetesabout 20 years ago
A Pharmacist's Guide to OTC Therapy: Diabetic Nutritional Supplementsabout 20 years ago
Tarceva Extends Lung Cancer Survivalabout 20 years ago
Inhaled Morphine Aids Cancer-related Dyspneaabout 20 years ago
Diuretic Best BP Therapy for African Americansabout 20 years ago
A Pharmacist's Guide to OTC Therapy: Diabetic Foot Care Productsabout 20 years ago
New Drug Blocks Out AIDS Virusabout 20 years ago
Viagra Ingredient Has Another Useabout 20 years ago
GUEST COMMENTARY: FIGHTING THE NEW PHARMACOPHOBIANewsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.